Authors
Loading...
Intratumoral myeloid cell treatment promotes CD8 T cell activation and tumor regression in mice, suggesting repeated treatment is crucial for effective antitumor immunity.
Jardim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: